Performance metric development for pharmaceutical construction projects

Aleem, 2003, Pharmaceutical process validation: an overview, Proceedings of the Institution of Mechanical Engineers, 217, 141, 10.1243/095440803766612801 Bender, 1996, Benchmark costs for pharmaceutical facilities, Pharmaceutical Engineering, 16, 28 ECI, 2008. About ECI. <http://www.eci-online.org/pages/aboutus.html> (accessed 29.12.2008). Hwang, B.G., 2006. Development of a Performance Measurement System for Pharmaceutical Capital Facilities Projects. Ph.D. Dissertation. The University of Texas at Austin, Austin, TX. Hwang, 2008, Development of a benchmarking framework for pharmaceutical capital projects, Construction Management and Economics, 26, 177, 10.1080/01446190701802398 IPA, 2008. About IPA. <http://www.ipaglobal.com/inside%20pages/About_IPA/index.html> (accessed 29.12.2008). ISPE (International Society of Pharmaceutical Engineers), 1996. Pharmaceutical Engineering Guide for Oral Solid Dosage Forms, vol. 2 (November), ISPE. ISPE, 1997. Pharmaceutical Engineering Guide for Bulk Pharmaceutical Chemical Facilities – Executive Summary, vol. 1 (November), ISPE. ISPE, 2003. Pharmaceutical Engineering Guide for biopharmaceuticals, vol. 6 (January), ISPE. ISPE, 2008. Glossary of Applied Terminology for the Pharmaceutical Industry, ISPE. http://www.ispe.org/glossary (accessed 29.09.2008). Osborne, 1996, Investment cost benchmarks for pharmaceutical facilities, Pharmaceutical Engineering, 16, 36 Valle, 2004, USA/EC/ISO regulatory considerations for designing aseptic processing facilities, Pharmaceutical Engineering, 24, 1 Wrigley, 2004